Literature DB >> 2552006

Vesicular stomatitis virus RNA replication: a role for the NS protein.

M Howard1, G Wertz.   

Abstract

Synthesis of the vesicular stomatitis virus nucleocapsid (N) protein is required for viral RNA replication. The observation that the N protein forms a rapidly sedimenting species in the absence of other viral proteins and the description of complexes of N protein with NS protein led to the proposal that NS protein binds to N protein to prevent it from self-associating. We tested this model by analysing the physical properties of N protein synthesized alone in an in vitro replication system as compared to N protein synthesized in the presence of the NS protein. These findings were correlated with the ability of the N protein, synthesized under both conditions, to support replication. N protein synthesized at low concentrations in the absence of other viral proteins sedimented at 4S on glycerol gradients and was capable of supporting RNA replication. In contrast, synthesis of increasing concentrations of N protein resulted in formation of a rapidly sedimenting species of N protein which had the physical properties of a protein-protein aggregate and which failed to support RNA replication. Co-synthesis of the NS protein with N protein both prevented the concentration-dependent aggregation of N and restored the ability of high concentrations of N protein to support RNA replication.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2552006     DOI: 10.1099/0022-1317-70-10-2683

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  40 in total

1.  Functional interaction map of lyssavirus phosphoprotein: identification of the minimal transcription domains.

Authors:  Y Jacob; E Real; N Tordo
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response.

Authors:  E B Flanagan; L A Ball; G W Wertz
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Adding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression.

Authors:  Gail W Wertz; Robin Moudy; L Andrew Ball
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

4.  Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro.

Authors:  S M Horikami; J Curran; D Kolakofsky; S A Moyer
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

5.  An amino acid of human parainfluenza virus type 3 nucleoprotein is critical for template function and cytoplasmic inclusion body formation.

Authors:  Shengwei Zhang; Longyun Chen; Guangyuan Zhang; Qin Yan; Xiaodan Yang; Binbin Ding; Qiaopeng Tang; Shengjun Sun; Zhulong Hu; Mingzhou Chen
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

6.  Mutations in the C-terminal loop of the nucleocapsid protein affect vesicular stomatitis virus RNA replication and transcription differentially.

Authors:  Djamila Harouaka; Gail W Wertz
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

7.  Characterization of the components and activity of Sonchus yellow net rhabdovirus polymerase.

Authors:  J D Wagner; A O Jackson
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  Conformational maturation of measles virus nucleocapsid protein.

Authors:  A F Gombart; A Hirano; T C Wong
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Importance of hydrogen bond contacts between the N protein and RNA genome of vesicular stomatitis virus in encapsidation and RNA synthesis.

Authors:  Edward W Rainsford; Djamila Harouaka; Gail W Wertz
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

10.  S-adenosyl homocysteine-induced hyperpolyadenylation of vesicular stomatitis virus mRNA requires the methyltransferase activity of L protein.

Authors:  Summer E Galloway; Gail W Wertz
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.